Uterine sarcoidosis potentially associated with interferon- alpha use ... Obstet Gynecol. 2005 May;105(5 Pt 2):1198-201. Uterine sarcoidosis potentially associated with interferon- alpha use ... www.ncbi.nlm.nih.gov/pubmed/15863580

Search Uterine sarcoidosis potentially associated with interferon-alpha use for chronic hepatitis C infection. Authors Tsiodras S, Drimala P, Stavreas N, Dachlythras M, Alamani AM, Naoum G. Journal Obstet Gynecol. 2005 May;105(5 Pt 2):1198-201. Affiliation Abstract BACKGROUND: A regimen including interferon-alpha has become the standard of care in the treatment of chronic hepatitis C over the last decade. One rare adverse effect associated with the use of interferon-alpha is a granulomatous pulmonary reaction. CASE: A unique case of uterine sarcoidosis associated with the use of interferon-alpha for chronic hepatitis C infection is presented. CONCLUSION: Gynecologists should be aware of a potential association between interferon-alpha therapy and granulomatous reactions occurring not only in the lung but also in the female genital tract. PMID 15863580 [PubMed - indexed for MEDLINE] Related Citations Show all Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature. Drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b. Standard PubMed NIH/NLM NCBI Copyright Help